GA2LEN NoE calls for more focus on allergies in FP7

The Network of Excellence (NoE) GA2LEN is urging policy makers to support the European Parliament's proposal to include allergic diseases in the health priorities of the Seventh Framework Programme (FP7).

While allergies are mentioned among the food research priorities in the European Commission's proposal, members of GA2LEN would like to see the wider allergy problem a top priority for health research. Only 8% of allergies in Europe are related to food.

"The absence of the wider allergy problem as a top concern in health research agenda threatens to compromise overall progress in the understanding of this complex condition," says the Network in a statement.

Allergies are a global problem, although the presentation and cause of the reactions vary. Researchers believe that the many different aspects of the condition, as well as its triggers, must be addressed if we are to gain a comprehensive understanding of allergic diseases as a whole.

Allergies can be fatal. According to the World Health Organization (WHO), asthma kills someone in Europe every hour. And the problem is becoming more widespread -one child in three is now allergic to something, and by 2015, half of all Europeans may be suffering from one or more allergic condition.

For sufferers, allergies can have a major impact of daily life. Children with allergic diseases miss days at school and must sometimes abstain from sport and other recreational activities, while breathing and skin problems dent the confidence of children and adults.

GA2LEN also highlights the financial costs of allergies, which estimates suggest amount to €100 billion per year.

The GA2LEN network brings together 26 allergy research centres around Europe with the aim of advancing diagnosis, prevention and treatment of allergic diseases. In recent months, a European database of comparable, longitudinal epidemiological studies, known has cohorts, has been completed. This should help scientists to conduct a more reliable analysis of the multiple genetic and environmental factors causing allergies.

For further information on GA2LEN, please visit:
http://www.ga2len.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...